HCPCS Level IIdrugActive
J1920
Inj, labetalol hcl, 5mg
BETOS: O1E
Effective: 2024-01-01
Description
Injection, labetalol hydrochloride, 5 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Labetalol HCl
Manufacturer
Hikma Pharmaceuticals USA Inc.
HCPCS Dosage
5 MG
Billing Units
20.0000
23
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.